Leflunomide in Combination With Decitabine

Phase I/II Study of Leflunomide in Combination With Decitabine for Treatment of Relapsed or Refractory (R/R) Myelodysplastic Syndromes (MDS)

More Information

Trial Status
Accepting patients
Trial Phase
Phase 1/2
Enrollment
26 patients (estimated)
Sponsors
West Virginia University
Tags
Disease-Modifying Antirheumatic Drug
Trial Type
Treatment
Last Update
SparkCures ID
2087
NCT Identifier
NCT06923488

Real People. Real Support.

Need help connecting with this clinical trial? We're here to help!

Print Report

Print a patient-friendly report to share with your patient.

(888) 803-1766

We can help answer any questions and connect you (or your patient) with the study team.

Schedule Call

Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.